Zakład Produkcji Sprzętu Medycznego Ravimedsp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-01-14
Share capital
50,000.00 PLN
Registered address
Polna 54, 05-119 Łajski, Poland
Electronic delivery address
AE:PL-69826-19488-IURFA-37

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 21 days early. 5 of 6 audited by a statutory auditor.

  • 202501/07/2026
  • 202408/07/2025
  • 202302/07/2024
  • 202204/07/2023
  • 202115/07/2022
  • 202026/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 15.19mMedianUSD 285.65kAverageUSD 4.89m
Net profit
This companyUSD 6.34mMedianUSD 12.41kAverageUSD 208.24k
Operating costs
This companyUSD 7.31mMedianUSD 269.12kAverageUSD 4.48m
Assets
This companyUSD 13.55mMedianUSD 227.14kAverageUSD 5.75m

Public procurement

4 tenders recorded as contractor: 1 national ($43,313) and 3 EU ($51,847,786).

SubjectAmount
WOFiTM/41/2025/PN – Supply of a medicinal product against chemical warfare agents for individual use in combat conditions and a painkiller for individual use in combat conditions in 2025-2027
$49.8M
Wofitm/25/2025/pn – supply of a medicinal product against chemical warfare agents (bśt) for individual administration in combat conditions and a painkiller for individual administration in combat conditions
$1.9M
Supply of the Individual Set of Auto-Injectors against Chemical Warfare Agents IZAS-05 and morphine auto-injectors for pain relief
$186.7K

Trademarks

Zakład Produkcji Sprzętu Medycznego Ravimed holds 2 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2000.

MarkNumberClassesStatusProtected until
RAVIMED(word)Z.3757055, 10, 42Protected Sep 23, 2030
SILVERCOL(word)Z.2231401, 3, 5, 10, 44Protected Aug 25, 2030
POLRYMANTADYNA(word)Z.3027655Expired –
MarkProtected until
RAVIMED(word)Sep 23, 2030
SILVERCOL(word)Aug 25, 2030
POLRYMANTADYNA(word)–

Authorized Representatives

Jerzy Piotr Bandolet – Management Board Member
Roman Konrad Raszewski – President of the Management Board
Wiesław Raszewski – V-Ce Prezes Zarządu

Manner of representation

A member of the management board acting individually.

Ownership

OwnerSharesShare valueStake
Jerzy Piotr Bandoletage 78
10$1,350.6210%
Roman Konrad Raszewskiage 53
80$10,804.9780%
Wiesław Raszewskiage 81
10$1,350.6210%

Roman Konrad Raszewski and Wiesław Raszewski hold a combined 90% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1994-01-01.

  • Bank Pekao SA
    31 1240 1040 1111 0010 9758 8598
  • Bank Pekao SA
    58 1240 1040 1111 0010 9952 4426
  • Bank spółdzielczy
    Bank spółdzielczy
    59 8013 0006 2001 0007 7073 0001

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 1.4M

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Regional investment aid
–

European Funds

ProjectEU co-financing
Launch of a modern production line at RAVIMED for blood collection, storage and processing container sets.
$1.3M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Metrum Cryoflexsp. z o.o.
Poldentsp. z o.o.
Corning HtlS.A.
Warszawskie Zakłady Sprzętu OrtopedycznegoS.A.
Tech-Med Technika Medyczna B.Wójciksp. j.
Metzer Medizin- Und Industrietechniksp. z o.o.
Endotradesp. z o.o.
Gokosp. z o.o.
Your Labsp. z o.o.
PhilabsS.A.

Change history

DateEvent
2015-07-13Switch to PKD 2007
2004-01-14Entered in the register

FAQ

Last updated: 2026-08-10